nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP3A7—Docetaxel—head and neck cancer	0.133	0.192	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.133	0.192	CbGbCtD
Nisoldipine—CYP3A5—Docetaxel—head and neck cancer	0.1	0.144	CbGbCtD
Nisoldipine—CYP1A2—Fluorouracil—head and neck cancer	0.0974	0.14	CbGbCtD
Nisoldipine—ABCB1—Vinblastine—head and neck cancer	0.0789	0.114	CbGbCtD
Nisoldipine—ABCB1—Docetaxel—head and neck cancer	0.0651	0.0937	CbGbCtD
Nisoldipine—CYP3A4—Vinblastine—head and neck cancer	0.0473	0.0681	CbGbCtD
Nisoldipine—CYP3A4—Docetaxel—head and neck cancer	0.039	0.0561	CbGbCtD
Nisoldipine—Tearing eyes—Docetaxel—head and neck cancer	0.0126	0.0508	CcSEcCtD
Nisoldipine—CACNA1D—cochlea—head and neck cancer	0.0103	0.24	CbGeAlD
Nisoldipine—CACNA1D—internal ear—head and neck cancer	0.0098	0.227	CbGeAlD
Nisoldipine—CACNA1D—ear—head and neck cancer	0.0066	0.153	CbGeAlD
Nisoldipine—Blepharitis—Hydroxyurea—head and neck cancer	0.00645	0.0261	CcSEcCtD
Nisoldipine—Skin ulcer—Hydroxyurea—head and neck cancer	0.0051	0.0206	CcSEcCtD
Nisoldipine—Cellulitis—Vinblastine—head and neck cancer	0.00478	0.0193	CcSEcCtD
Nisoldipine—Blepharitis—Fluorouracil—head and neck cancer	0.00464	0.0188	CcSEcCtD
Nisoldipine—Chest tightness—Docetaxel—head and neck cancer	0.0044	0.0178	CcSEcCtD
Nisoldipine—Blood urea increased—Hydroxyurea—head and neck cancer	0.00375	0.0151	CcSEcCtD
Nisoldipine—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00361	0.0146	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00322	0.013	CcSEcCtD
Nisoldipine—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00315	0.0127	CcSEcCtD
Nisoldipine—Cellulitis—Fluorouracil—head and neck cancer	0.00314	0.0127	CcSEcCtD
Nisoldipine—Lacrimation increased—Fluorouracil—head and neck cancer	0.0031	0.0125	CcSEcCtD
Nisoldipine—Herpes simplex—Fluorouracil—head and neck cancer	0.0031	0.0125	CcSEcCtD
Nisoldipine—Face oedema—Hydroxyurea—head and neck cancer	0.00278	0.0112	CcSEcCtD
Nisoldipine—Pleural effusion—Docetaxel—head and neck cancer	0.00269	0.0109	CcSEcCtD
Nisoldipine—Otitis media—Docetaxel—head and neck cancer	0.00265	0.0107	CcSEcCtD
Nisoldipine—Rash maculo-papular—Fluorouracil—head and neck cancer	0.0026	0.0105	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0024	0.0097	CcSEcCtD
Nisoldipine—Myocardial infarction—Vinblastine—head and neck cancer	0.00239	0.00964	CcSEcCtD
Nisoldipine—Chest discomfort—Docetaxel—head and neck cancer	0.00233	0.00942	CcSEcCtD
Nisoldipine—Dysuria—Hydroxyurea—head and neck cancer	0.00233	0.00941	CcSEcCtD
Nisoldipine—Weight increased—Hydroxyurea—head and neck cancer	0.00227	0.00916	CcSEcCtD
Nisoldipine—Lacrimation increased—Docetaxel—head and neck cancer	0.00224	0.00904	CcSEcCtD
Nisoldipine—Amnesia—Fluorouracil—head and neck cancer	0.00221	0.00892	CcSEcCtD
Nisoldipine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00217	0.00879	CcSEcCtD
Nisoldipine—Pharyngitis—Vinblastine—head and neck cancer	0.00217	0.00876	CcSEcCtD
Nisoldipine—Stomatitis—Hydroxyurea—head and neck cancer	0.00216	0.00874	CcSEcCtD
Nisoldipine—CACNA1S—thyroid gland—head and neck cancer	0.00212	0.0491	CbGeAlD
Nisoldipine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00207	0.00838	CcSEcCtD
Nisoldipine—Colitis—Docetaxel—head and neck cancer	0.00198	0.008	CcSEcCtD
Nisoldipine—Ataxia—Fluorouracil—head and neck cancer	0.00195	0.00788	CcSEcCtD
Nisoldipine—Alopecia—Vinblastine—head and neck cancer	0.00193	0.0078	CcSEcCtD
Nisoldipine—Dry skin—Fluorouracil—head and neck cancer	0.0019	0.00768	CcSEcCtD
Nisoldipine—Muscular weakness—Fluorouracil—head and neck cancer	0.00183	0.00739	CcSEcCtD
Nisoldipine—Dysphagia—Fluorouracil—head and neck cancer	0.00179	0.00724	CcSEcCtD
Nisoldipine—Chills—Hydroxyurea—head and neck cancer	0.00179	0.00723	CcSEcCtD
Nisoldipine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00176	0.00713	CcSEcCtD
Nisoldipine—Alopecia—Hydroxyurea—head and neck cancer	0.00176	0.00712	CcSEcCtD
Nisoldipine—Anaemia—Vinblastine—head and neck cancer	0.00176	0.0071	CcSEcCtD
Nisoldipine—Malaise—Vinblastine—head and neck cancer	0.00172	0.00693	CcSEcCtD
Nisoldipine—Vertigo—Vinblastine—head and neck cancer	0.00171	0.00691	CcSEcCtD
Nisoldipine—Leukopenia—Vinblastine—head and neck cancer	0.0017	0.00688	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00165	0.00667	CcSEcCtD
Nisoldipine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00161	0.0065	CcSEcCtD
Nisoldipine—Anaemia—Hydroxyurea—head and neck cancer	0.0016	0.00648	CcSEcCtD
Nisoldipine—Discomfort—Vinblastine—head and neck cancer	0.0016	0.00647	CcSEcCtD
Nisoldipine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00158	0.00638	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00157	0.00636	CcSEcCtD
Nisoldipine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00157	0.00633	CcSEcCtD
Nisoldipine—Malaise—Hydroxyurea—head and neck cancer	0.00156	0.00632	CcSEcCtD
Nisoldipine—Stomatitis—Fluorouracil—head and neck cancer	0.00156	0.00629	CcSEcCtD
Nisoldipine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00155	0.00628	CcSEcCtD
Nisoldipine—Leukopenia—Hydroxyurea—head and neck cancer	0.00155	0.00627	CcSEcCtD
Nisoldipine—CACNA1C—connective tissue—head and neck cancer	0.00154	0.0358	CbGeAlD
Nisoldipine—Epistaxis—Fluorouracil—head and neck cancer	0.00151	0.00609	CcSEcCtD
Nisoldipine—Sinusitis—Fluorouracil—head and neck cancer	0.0015	0.00606	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.0015	0.00605	CcSEcCtD
Nisoldipine—Amlodipine—CYP1A1—head and neck cancer	0.00148	0.528	CrCbGaD
Nisoldipine—Anorexia—Vinblastine—head and neck cancer	0.00148	0.00598	CcSEcCtD
Nisoldipine—Migraine—Docetaxel—head and neck cancer	0.00147	0.00595	CcSEcCtD
Nisoldipine—Discomfort—Hydroxyurea—head and neck cancer	0.00146	0.0059	CcSEcCtD
Nisoldipine—Rhinitis—Fluorouracil—head and neck cancer	0.00144	0.00581	CcSEcCtD
Nisoldipine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00143	0.00577	CcSEcCtD
Nisoldipine—Pharyngitis—Fluorouracil—head and neck cancer	0.00142	0.00575	CcSEcCtD
Nisoldipine—Oedema—Hydroxyurea—head and neck cancer	0.00142	0.00572	CcSEcCtD
Nisoldipine—Ataxia—Docetaxel—head and neck cancer	0.00141	0.00569	CcSEcCtD
Nisoldipine—Paraesthesia—Vinblastine—head and neck cancer	0.00139	0.00563	CcSEcCtD
Nisoldipine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00138	0.00558	CcSEcCtD
Nisoldipine—Dry skin—Docetaxel—head and neck cancer	0.00137	0.00554	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00137	0.00552	CcSEcCtD
Nisoldipine—Anorexia—Hydroxyurea—head and neck cancer	0.00135	0.00545	CcSEcCtD
Nisoldipine—Decreased appetite—Vinblastine—head and neck cancer	0.00135	0.00545	CcSEcCtD
Nisoldipine—Nifedipine—CYP1A1—head and neck cancer	0.00133	0.472	CrCbGaD
Nisoldipine—Dysphagia—Docetaxel—head and neck cancer	0.00129	0.00523	CcSEcCtD
Nisoldipine—Feeling abnormal—Vinblastine—head and neck cancer	0.00128	0.00517	CcSEcCtD
Nisoldipine—CACNB2—thyroid gland—head and neck cancer	0.00127	0.0295	CbGeAlD
Nisoldipine—Alopecia—Fluorouracil—head and neck cancer	0.00127	0.00512	CcSEcCtD
Nisoldipine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00126	0.0051	CcSEcCtD
Nisoldipine—Somnolence—Hydroxyurea—head and neck cancer	0.00126	0.00509	CcSEcCtD
Nisoldipine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00125	0.00504	CcSEcCtD
Nisoldipine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00123	0.00497	CcSEcCtD
Nisoldipine—CACNA2D1—thyroid gland—head and neck cancer	0.00119	0.0277	CbGeAlD
Nisoldipine—Weight increased—Docetaxel—head and neck cancer	0.00118	0.00476	CcSEcCtD
Nisoldipine—Weight decreased—Docetaxel—head and neck cancer	0.00117	0.00473	CcSEcCtD
Nisoldipine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00117	0.00471	CcSEcCtD
Nisoldipine—Anaemia—Fluorouracil—head and neck cancer	0.00115	0.00466	CcSEcCtD
Nisoldipine—Hypersensitivity—Vinblastine—head and neck cancer	0.00114	0.00462	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00114	0.00459	CcSEcCtD
Nisoldipine—Myocardial infarction—Docetaxel—head and neck cancer	0.00113	0.00457	CcSEcCtD
Nisoldipine—CACNB2—head—head and neck cancer	0.00113	0.0262	CbGeAlD
Nisoldipine—Stomatitis—Docetaxel—head and neck cancer	0.00112	0.00454	CcSEcCtD
Nisoldipine—Conjunctivitis—Docetaxel—head and neck cancer	0.00112	0.00453	CcSEcCtD
Nisoldipine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00112	0.00452	CcSEcCtD
Nisoldipine—Leukopenia—Fluorouracil—head and neck cancer	0.00112	0.00452	CcSEcCtD
Nisoldipine—CACNA1D—thyroid gland—head and neck cancer	0.00111	0.0258	CbGeAlD
Nisoldipine—Epistaxis—Docetaxel—head and neck cancer	0.00109	0.0044	CcSEcCtD
Nisoldipine—Chest pain—Fluorouracil—head and neck cancer	0.00106	0.0043	CcSEcCtD
Nisoldipine—Myalgia—Fluorouracil—head and neck cancer	0.00106	0.0043	CcSEcCtD
Nisoldipine—Diarrhoea—Vinblastine—head and neck cancer	0.00106	0.00429	CcSEcCtD
Nisoldipine—CACNA2D1—head—head and neck cancer	0.00106	0.0246	CbGeAlD
Nisoldipine—Discomfort—Fluorouracil—head and neck cancer	0.00105	0.00424	CcSEcCtD
Nisoldipine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00104	0.00421	CcSEcCtD
Nisoldipine—Rhinitis—Docetaxel—head and neck cancer	0.00104	0.00419	CcSEcCtD
Nisoldipine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00103	0.00416	CcSEcCtD
Nisoldipine—Confusional state—Fluorouracil—head and neck cancer	0.00103	0.00415	CcSEcCtD
Nisoldipine—Pharyngitis—Docetaxel—head and neck cancer	0.00103	0.00415	CcSEcCtD
Nisoldipine—Dizziness—Vinblastine—head and neck cancer	0.00103	0.00415	CcSEcCtD
Nisoldipine—Oedema peripheral—Docetaxel—head and neck cancer	0.00102	0.00412	CcSEcCtD
Nisoldipine—Oedema—Fluorouracil—head and neck cancer	0.00102	0.00412	CcSEcCtD
Nisoldipine—Visual impairment—Docetaxel—head and neck cancer	0.000998	0.00403	CcSEcCtD
Nisoldipine—Tachycardia—Fluorouracil—head and neck cancer	0.000994	0.00402	CcSEcCtD
Nisoldipine—CACNA1D—head—head and neck cancer	0.000986	0.0229	CbGeAlD
Nisoldipine—Headache—Vinblastine—head and neck cancer	0.000972	0.00393	CcSEcCtD
Nisoldipine—Anorexia—Fluorouracil—head and neck cancer	0.000971	0.00393	CcSEcCtD
Nisoldipine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000969	0.00391	CcSEcCtD
Nisoldipine—Hypotension—Fluorouracil—head and neck cancer	0.000952	0.00385	CcSEcCtD
Nisoldipine—Dizziness—Hydroxyurea—head and neck cancer	0.000936	0.00378	CcSEcCtD
Nisoldipine—Chills—Docetaxel—head and neck cancer	0.000929	0.00375	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000928	0.00375	CcSEcCtD
Nisoldipine—Nausea—Vinblastine—head and neck cancer	0.000922	0.00373	CcSEcCtD
Nisoldipine—Insomnia—Fluorouracil—head and neck cancer	0.000922	0.00372	CcSEcCtD
Nisoldipine—Paraesthesia—Fluorouracil—head and neck cancer	0.000915	0.0037	CcSEcCtD
Nisoldipine—Alopecia—Docetaxel—head and neck cancer	0.000915	0.0037	CcSEcCtD
Nisoldipine—CACNA1C—head—head and neck cancer	0.00091	0.0211	CbGeAlD
Nisoldipine—Dyspnoea—Fluorouracil—head and neck cancer	0.000908	0.00367	CcSEcCtD
Nisoldipine—Somnolence—Fluorouracil—head and neck cancer	0.000906	0.00366	CcSEcCtD
Nisoldipine—Dyspepsia—Fluorouracil—head and neck cancer	0.000897	0.00362	CcSEcCtD
Nisoldipine—Rash—Hydroxyurea—head and neck cancer	0.000893	0.00361	CcSEcCtD
Nisoldipine—Dermatitis—Hydroxyurea—head and neck cancer	0.000892	0.0036	CcSEcCtD
Nisoldipine—Headache—Hydroxyurea—head and neck cancer	0.000887	0.00358	CcSEcCtD
Nisoldipine—Decreased appetite—Fluorouracil—head and neck cancer	0.000886	0.00358	CcSEcCtD
Nisoldipine—Dysgeusia—Docetaxel—head and neck cancer	0.000882	0.00357	CcSEcCtD
Nisoldipine—Muscle spasms—Docetaxel—head and neck cancer	0.000866	0.0035	CcSEcCtD
Nisoldipine—Nausea—Hydroxyurea—head and neck cancer	0.000841	0.0034	CcSEcCtD
Nisoldipine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00084	0.00339	CcSEcCtD
Nisoldipine—Anaemia—Docetaxel—head and neck cancer	0.000833	0.00337	CcSEcCtD
Nisoldipine—Urticaria—Fluorouracil—head and neck cancer	0.000809	0.00327	CcSEcCtD
Nisoldipine—Syncope—Docetaxel—head and neck cancer	0.000808	0.00327	CcSEcCtD
Nisoldipine—Leukopenia—Docetaxel—head and neck cancer	0.000807	0.00326	CcSEcCtD
Nisoldipine—Body temperature increased—Fluorouracil—head and neck cancer	0.000806	0.00326	CcSEcCtD
Nisoldipine—Palpitations—Docetaxel—head and neck cancer	0.000796	0.00322	CcSEcCtD
Nisoldipine—Loss of consciousness—Docetaxel—head and neck cancer	0.000792	0.0032	CcSEcCtD
Nisoldipine—CACNB2—lymph node—head and neck cancer	0.00079	0.0183	CbGeAlD
Nisoldipine—Cough—Docetaxel—head and neck cancer	0.000786	0.00318	CcSEcCtD
Nisoldipine—Chest pain—Docetaxel—head and neck cancer	0.000767	0.0031	CcSEcCtD
Nisoldipine—Myalgia—Docetaxel—head and neck cancer	0.000767	0.0031	CcSEcCtD
Nisoldipine—Arthralgia—Docetaxel—head and neck cancer	0.000767	0.0031	CcSEcCtD
Nisoldipine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000751	0.00303	CcSEcCtD
Nisoldipine—Dry mouth—Docetaxel—head and neck cancer	0.00075	0.00303	CcSEcCtD
Nisoldipine—CACNA2D1—lymph node—head and neck cancer	0.000742	0.0172	CbGeAlD
Nisoldipine—Confusional state—Docetaxel—head and neck cancer	0.000742	0.003	CcSEcCtD
Nisoldipine—Oedema—Docetaxel—head and neck cancer	0.000735	0.00297	CcSEcCtD
Nisoldipine—Shock—Docetaxel—head and neck cancer	0.000724	0.00292	CcSEcCtD
Nisoldipine—Pruritus—Fluorouracil—head and neck cancer	0.000721	0.00291	CcSEcCtD
Nisoldipine—Tachycardia—Docetaxel—head and neck cancer	0.000718	0.0029	CcSEcCtD
Nisoldipine—Anorexia—Docetaxel—head and neck cancer	0.000701	0.00283	CcSEcCtD
Nisoldipine—Diarrhoea—Fluorouracil—head and neck cancer	0.000697	0.00282	CcSEcCtD
Nisoldipine—CACNA1D—lymph node—head and neck cancer	0.00069	0.016	CbGeAlD
Nisoldipine—Hypotension—Docetaxel—head and neck cancer	0.000687	0.00278	CcSEcCtD
Nisoldipine—Dizziness—Fluorouracil—head and neck cancer	0.000674	0.00272	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00067	0.00271	CcSEcCtD
Nisoldipine—Insomnia—Docetaxel—head and neck cancer	0.000665	0.00269	CcSEcCtD
Nisoldipine—Paraesthesia—Docetaxel—head and neck cancer	0.00066	0.00267	CcSEcCtD
Nisoldipine—Dyspnoea—Docetaxel—head and neck cancer	0.000656	0.00265	CcSEcCtD
Nisoldipine—Somnolence—Docetaxel—head and neck cancer	0.000654	0.00264	CcSEcCtD
Nisoldipine—Dyspepsia—Docetaxel—head and neck cancer	0.000647	0.00262	CcSEcCtD
Nisoldipine—Rash—Fluorouracil—head and neck cancer	0.000642	0.0026	CcSEcCtD
Nisoldipine—Dermatitis—Fluorouracil—head and neck cancer	0.000642	0.00259	CcSEcCtD
Nisoldipine—Decreased appetite—Docetaxel—head and neck cancer	0.000639	0.00258	CcSEcCtD
Nisoldipine—Headache—Fluorouracil—head and neck cancer	0.000638	0.00258	CcSEcCtD
Nisoldipine—CACNA1C—lymph node—head and neck cancer	0.000637	0.0148	CbGeAlD
Nisoldipine—Feeling abnormal—Docetaxel—head and neck cancer	0.000606	0.00245	CcSEcCtD
Nisoldipine—Nausea—Fluorouracil—head and neck cancer	0.000605	0.00245	CcSEcCtD
Nisoldipine—Body temperature increased—Docetaxel—head and neck cancer	0.000581	0.00235	CcSEcCtD
Nisoldipine—Hypersensitivity—Docetaxel—head and neck cancer	0.000542	0.00219	CcSEcCtD
Nisoldipine—CYP1A2—thyroid gland—head and neck cancer	0.000523	0.0121	CbGeAlD
Nisoldipine—Pruritus—Docetaxel—head and neck cancer	0.00052	0.0021	CcSEcCtD
Nisoldipine—Diarrhoea—Docetaxel—head and neck cancer	0.000503	0.00203	CcSEcCtD
Nisoldipine—Dizziness—Docetaxel—head and neck cancer	0.000486	0.00197	CcSEcCtD
Nisoldipine—Rash—Docetaxel—head and neck cancer	0.000464	0.00187	CcSEcCtD
Nisoldipine—Dermatitis—Docetaxel—head and neck cancer	0.000463	0.00187	CcSEcCtD
Nisoldipine—Headache—Docetaxel—head and neck cancer	0.000461	0.00186	CcSEcCtD
Nisoldipine—Nausea—Docetaxel—head and neck cancer	0.000437	0.00177	CcSEcCtD
Nisoldipine—ABCB1—epithelium—head and neck cancer	0.000383	0.00889	CbGeAlD
Nisoldipine—ABCB1—trachea—head and neck cancer	0.000339	0.00786	CbGeAlD
Nisoldipine—ABCB1—lymphoid tissue—head and neck cancer	0.000295	0.00685	CbGeAlD
Nisoldipine—ABCB1—thyroid gland—head and neck cancer	0.000268	0.00622	CbGeAlD
Nisoldipine—ABCB1—head—head and neck cancer	0.000238	0.00552	CbGeAlD
Nisoldipine—ABCB1—lymph node—head and neck cancer	0.000167	0.00386	CbGeAlD
Nisoldipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.26e-05	0.00757	CbGpPWpGaD
Nisoldipine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	9.24e-05	0.00756	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	8.98e-05	0.00735	CbGpPWpGaD
Nisoldipine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	8.89e-05	0.00728	CbGpPWpGaD
Nisoldipine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	8.89e-05	0.00727	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—MAPK1—head and neck cancer	8.84e-05	0.00723	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—CEBPA—head and neck cancer	8.67e-05	0.00709	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	8.55e-05	0.00699	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	8.51e-05	0.00696	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—UROD—head and neck cancer	8.49e-05	0.00694	CbGpPWpGaD
Nisoldipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.25e-05	0.00675	CbGpPWpGaD
Nisoldipine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.15e-05	0.00666	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	8.1e-05	0.00662	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—UROD—head and neck cancer	8.04e-05	0.00658	CbGpPWpGaD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	8.01e-05	0.00655	CbGpPWpGaD
Nisoldipine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	7.84e-05	0.00641	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	7.82e-05	0.00639	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—NAT2—head and neck cancer	7.59e-05	0.00621	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—MAPK3—head and neck cancer	7.55e-05	0.00617	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	7.49e-05	0.00612	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	7.48e-05	0.00612	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—TP53—head and neck cancer	7.42e-05	0.00607	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—MAPK1—head and neck cancer	7.18e-05	0.00587	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	7.11e-05	0.00582	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—UROD—head and neck cancer	7.06e-05	0.00578	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	6.86e-05	0.00561	CbGpPWpGaD
Nisoldipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.69e-05	0.00547	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—MAPK3—head and neck cancer	6.63e-05	0.00542	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	6.5e-05	0.00532	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—MAPK1—head and neck cancer	6.31e-05	0.00516	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	6.15e-05	0.00503	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	6.15e-05	0.00503	CbGpPWpGaD
Nisoldipine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	6.15e-05	0.00503	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—TP53—head and neck cancer	6.03e-05	0.00493	CbGpPWpGaD
Nisoldipine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	5.81e-05	0.00475	CbGpPWpGaD
Nisoldipine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	5.75e-05	0.00471	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	5.71e-05	0.00467	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—TP53—head and neck cancer	5.3e-05	0.00433	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	5.19e-05	0.00424	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	5.12e-05	0.00418	CbGpPWpGaD
Nisoldipine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.97e-05	0.00407	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	4.92e-05	0.00402	CbGpPWpGaD
Nisoldipine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.91e-05	0.00401	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	4.85e-05	0.00397	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	4.82e-05	0.00394	CbGpPWpGaD
Nisoldipine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	4.75e-05	0.00388	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	4.57e-05	0.00374	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	4.51e-05	0.00369	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	4.38e-05	0.00359	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—UROD—head and neck cancer	4.33e-05	0.00354	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.03e-05	0.0033	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—NOTCH1—head and neck cancer	3.88e-05	0.00317	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	3.86e-05	0.00316	CbGpPWpGaD
Nisoldipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	3.84e-05	0.00314	CbGpPWpGaD
Nisoldipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	3.79e-05	0.0031	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	3.75e-05	0.00307	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	3.7e-05	0.00302	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	3.66e-05	0.00299	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	3.65e-05	0.00298	CbGpPWpGaD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	3.61e-05	0.00295	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	3.55e-05	0.00291	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	3.53e-05	0.00289	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—NAT2—head and neck cancer	3.52e-05	0.00288	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	3.51e-05	0.00287	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	3.48e-05	0.00285	CbGpPWpGaD
Nisoldipine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	3.42e-05	0.0028	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	3.39e-05	0.00277	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—NAT2—head and neck cancer	3.34e-05	0.00273	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—NOTCH1—head and neck cancer	3.32e-05	0.00272	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—VEGFA—head and neck cancer	3.18e-05	0.0026	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—NOTCH1—head and neck cancer	3.15e-05	0.00257	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—UROD—head and neck cancer	3.13e-05	0.00256	CbGpPWpGaD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.11e-05	0.00254	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—DPYD—head and neck cancer	3.09e-05	0.00253	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—MAPK3—head and neck cancer	3.01e-05	0.00246	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NAT2—head and neck cancer	2.93e-05	0.0024	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—YAP1—head and neck cancer	2.93e-05	0.0024	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—DPYD—head and neck cancer	2.93e-05	0.00239	CbGpPWpGaD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—HRAS—head and neck cancer	2.9e-05	0.00237	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	2.88e-05	0.00236	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—MAPK1—head and neck cancer	2.86e-05	0.00234	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—EGFR—head and neck cancer	2.86e-05	0.00234	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—YAP1—head and neck cancer	2.78e-05	0.00227	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—NOTCH1—head and neck cancer	2.77e-05	0.00226	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—MAPK1—head and neck cancer	2.76e-05	0.00226	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL2—head and neck cancer	2.75e-05	0.00225	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—VEGFA—head and neck cancer	2.72e-05	0.00223	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	2.7e-05	0.00221	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	2.65e-05	0.00216	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	2.63e-05	0.00215	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	2.59e-05	0.00212	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	2.59e-05	0.00212	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	2.59e-05	0.00212	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—VEGFA—head and neck cancer	2.58e-05	0.00211	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MAPK3—head and neck cancer	2.58e-05	0.00211	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—DPYD—head and neck cancer	2.57e-05	0.0021	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MAPK1—head and neck cancer	2.45e-05	0.00201	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—EGFR—head and neck cancer	2.45e-05	0.00201	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—YAP1—head and neck cancer	2.44e-05	0.002	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MAPK3—head and neck cancer	2.44e-05	0.002	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—UROD—head and neck cancer	2.36e-05	0.00193	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	2.34e-05	0.00192	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MAPK1—head and neck cancer	2.32e-05	0.0019	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—EGFR—head and neck cancer	2.32e-05	0.0019	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—HRAS—head and neck cancer	2.3e-05	0.00188	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—VEGFA—head and neck cancer	2.27e-05	0.00185	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—VEGFA—head and neck cancer	2.27e-05	0.00185	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	2.26e-05	0.00185	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—STAT3—head and neck cancer	2.24e-05	0.00184	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	2.23e-05	0.00182	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—HRAS—head and neck cancer	2.22e-05	0.00181	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MAPK3—head and neck cancer	2.14e-05	0.00175	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MAPK3—head and neck cancer	2.14e-05	0.00175	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	2.14e-05	0.00175	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	2.11e-05	0.00173	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	2.08e-05	0.0017	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MAPK1—head and neck cancer	2.04e-05	0.00167	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—EGFR—head and neck cancer	2.04e-05	0.00167	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MAPK1—head and neck cancer	2.04e-05	0.00167	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—EGFR—head and neck cancer	2.04e-05	0.00167	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—HRAS—head and neck cancer	1.97e-05	0.00161	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—VEGFA—head and neck cancer	1.94e-05	0.00159	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—STAT3—head and neck cancer	1.92e-05	0.00157	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—UROD—head and neck cancer	1.88e-05	0.00154	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—HRAS—head and neck cancer	1.86e-05	0.00152	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—VEGFA—head and neck cancer	1.84e-05	0.00151	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MAPK3—head and neck cancer	1.84e-05	0.0015	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—STAT3—head and neck cancer	1.82e-05	0.00149	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.8e-05	0.00147	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NAT2—head and neck cancer	1.8e-05	0.00147	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—TYMS—head and neck cancer	1.76e-05	0.00144	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MAPK1—head and neck cancer	1.75e-05	0.00143	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—EGFR—head and neck cancer	1.75e-05	0.00143	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.74e-05	0.00143	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MAPK3—head and neck cancer	1.74e-05	0.00142	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GSTM1—head and neck cancer	1.74e-05	0.00142	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.72e-05	0.00141	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.72e-05	0.00141	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—TYMS—head and neck cancer	1.67e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GPX1—head and neck cancer	1.67e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MAPK1—head and neck cancer	1.66e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—EGFR—head and neck cancer	1.66e-05	0.00136	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.65e-05	0.00135	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP1A1—head and neck cancer	1.65e-05	0.00135	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GSTM1—head and neck cancer	1.65e-05	0.00135	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—HRAS—head and neck cancer	1.64e-05	0.00134	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—HRAS—head and neck cancer	1.64e-05	0.00134	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.63e-05	0.00133	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—VEGFA—head and neck cancer	1.62e-05	0.00132	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—STAT3—head and neck cancer	1.6e-05	0.00131	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GPX1—head and neck cancer	1.58e-05	0.00129	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—DPYD—head and neck cancer	1.57e-05	0.00129	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP1A1—head and neck cancer	1.56e-05	0.00128	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.54e-05	0.00126	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MAPK3—head and neck cancer	1.53e-05	0.00125	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—YAP1—head and neck cancer	1.49e-05	0.00122	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.47e-05	0.0012	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—TYMS—head and neck cancer	1.47e-05	0.0012	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.46e-05	0.0012	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MAPK1—head and neck cancer	1.46e-05	0.00119	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—EGFR—head and neck cancer	1.46e-05	0.00119	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—UROD—head and neck cancer	1.45e-05	0.00119	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GSTM1—head and neck cancer	1.45e-05	0.00118	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—AKT1—head and neck cancer	1.45e-05	0.00118	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—HRAS—head and neck cancer	1.4e-05	0.00115	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GPX1—head and neck cancer	1.39e-05	0.00113	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.00112	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—HRAS—head and neck cancer	1.33e-05	0.00109	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.33e-05	0.00108	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NAT2—head and neck cancer	1.3e-05	0.00106	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.28e-05	0.00105	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—AKT1—head and neck cancer	1.24e-05	0.00101	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—AKT1—head and neck cancer	1.17e-05	0.000961	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—HRAS—head and neck cancer	1.17e-05	0.000956	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.16e-05	0.000945	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—DPYD—head and neck cancer	1.14e-05	0.000931	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.09e-05	0.000894	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—YAP1—head and neck cancer	1.08e-05	0.000884	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.04e-05	0.000851	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.04e-05	0.000851	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—AKT1—head and neck cancer	1.03e-05	0.000844	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTGS2—head and neck cancer	9.81e-06	0.000803	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NAT2—head and neck cancer	9.8e-06	0.000801	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTGS2—head and neck cancer	9.29e-06	0.00076	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	9.02e-06	0.000738	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—TYMS—head and neck cancer	8.97e-06	0.000734	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTM1—head and neck cancer	8.87e-06	0.000726	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	8.73e-06	0.000714	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—DPYD—head and neck cancer	8.59e-06	0.000703	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTEN—head and neck cancer	8.56e-06	0.0007	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GPX1—head and neck cancer	8.49e-06	0.000695	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP1A1—head and neck cancer	8.41e-06	0.000688	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.31e-06	0.000679	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.22e-06	0.000673	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTGS2—head and neck cancer	8.17e-06	0.000668	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—YAP1—head and neck cancer	8.15e-06	0.000667	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTEN—head and neck cancer	8.11e-06	0.000663	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NAT2—head and neck cancer	7.82e-06	0.00064	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.37e-06	0.000603	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTEN—head and neck cancer	7.12e-06	0.000583	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—DPYD—head and neck cancer	6.86e-06	0.000561	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—YAP1—head and neck cancer	6.51e-06	0.000532	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—TYMS—head and neck cancer	6.49e-06	0.000531	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTM1—head and neck cancer	6.41e-06	0.000525	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GPX1—head and neck cancer	6.14e-06	0.000502	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	6.08e-06	0.000497	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PIK3CA—head and neck cancer	6.04e-06	0.000494	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NAT2—head and neck cancer	6.04e-06	0.000494	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PIK3CA—head and neck cancer	5.72e-06	0.000468	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—DPYD—head and neck cancer	5.29e-06	0.000433	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PIK3CA—head and neck cancer	5.02e-06	0.000411	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—YAP1—head and neck cancer	5.02e-06	0.000411	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTGS2—head and neck cancer	5e-06	0.000409	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—AKT1—head and neck cancer	4.93e-06	0.000404	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—TYMS—head and neck cancer	4.89e-06	0.0004	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.89e-06	0.0004	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTM1—head and neck cancer	4.84e-06	0.000396	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—AKT1—head and neck cancer	4.67e-06	0.000382	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GPX1—head and neck cancer	4.63e-06	0.000379	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP1A1—head and neck cancer	4.59e-06	0.000375	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTEN—head and neck cancer	4.36e-06	0.000357	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.26e-06	0.000349	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—AKT1—head and neck cancer	4.1e-06	0.000336	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—TYMS—head and neck cancer	3.91e-06	0.00032	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.86e-06	0.000316	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GPX1—head and neck cancer	3.7e-06	0.000303	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.66e-06	0.0003	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTGS2—head and neck cancer	3.61e-06	0.000296	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTEN—head and neck cancer	3.15e-06	0.000258	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PIK3CA—head and neck cancer	3.08e-06	0.000252	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—TYMS—head and neck cancer	3.02e-06	0.000247	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.01e-06	0.000246	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.98e-06	0.000244	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GPX1—head and neck cancer	2.85e-06	0.000234	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.83e-06	0.000231	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTGS2—head and neck cancer	2.73e-06	0.000223	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—AKT1—head and neck cancer	2.51e-06	0.000206	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTEN—head and neck cancer	2.38e-06	0.000195	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.22e-06	0.000182	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.18e-06	0.000178	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTEN—head and neck cancer	1.9e-06	0.000155	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—AKT1—head and neck cancer	1.82e-06	0.000149	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.68e-06	0.000137	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.68e-06	0.000137	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTEN—head and neck cancer	1.47e-06	0.00012	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AKT1—head and neck cancer	1.37e-06	0.000112	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.34e-06	0.00011	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AKT1—head and neck cancer	1.09e-06	8.95e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.03e-06	8.46e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AKT1—head and neck cancer	8.45e-07	6.91e-05	CbGpPWpGaD
